Clinical Trial: Bioequivalence Study of Valsatril Tablet Versus Entresto(R) (Sacubitril/Valsartan 24/26mg) 24mg/26mg Tablet.

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07746908) titled 'Bioequivalence Study of Valsatril Tablet Versus Entresto(R) (Sacubitril/Valsartan 24/26mg) 24mg/26mg Tablet.' on July 25.

Brief Summary: This study is to evaluate the bioequivalence of Valsatril (Sacubitril/Valsartan) tablet 50 mg versus Entresto 50 mg tablet in healthy Pakistani volunteers under Fasting condition.

Study Start Date: Feb. 06, 2025

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: Valsatril(R)

(Sacubitril/Valsartan) 24 mg/26 mg tablet of SAMI Pharmaceuticals (Pvt) Ltd

DRUG: Entresto(R)

Entresto(R) (Sacubitril/Valsartan) 24 mg/26 mg tablet of Novartis Pharmaceuticals Ltd

Recruitmen...